Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Dexcom (DXCM) over the last 12 years, with Q4 2025 value amounting to $73.4 million.

  • Dexcom's Tax Provisions rose 2315.44% to $73.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $252.1 million, marking a year-over-year increase of 8983.43%. This contributed to the annual value of $252.1 million for FY2025, which is 8983.43% up from last year.
  • Latest data reveals that Dexcom reported Tax Provisions of $73.4 million as of Q4 2025, which was up 2315.44% from $68.5 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Tax Provisions ranged from a high of $119.7 million in Q3 2023 and a low of -$61.2 million during Q1 2022
  • Its 5-year average for Tax Provisions is $32.2 million, with a median of $42.1 million in 2022.
  • The largest annual percentage gain for Dexcom's Tax Provisions in the last 5 years was 1880000.0% (2021), contrasted with its biggest fall of 70800.0% (2021).
  • Quarter analysis of 5 years shows Dexcom's Tax Provisions stood at $11.7 million in 2021, then soared by 253.85% to $41.4 million in 2022, then crashed by 124.4% to -$10.1 million in 2023, then soared by 690.1% to $59.6 million in 2024, then rose by 23.15% to $73.4 million in 2025.
  • Its Tax Provisions was $73.4 million in Q4 2025, compared to $68.5 million in Q3 2025 and $61.3 million in Q2 2025.